These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6662196

  • 21. Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: central dopamine receptor activity.
    Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson AM, Thorberg SO, Nilsson JL, Svensson K, Hjorth S.
    J Med Chem; 1984 Aug; 27(8):1030-6. PubMed ID: 6086923
    [Abstract] [Full Text] [Related]

  • 22. The intrinsic activity of (-)-3-PPP (preclamol) on pituitary DA receptors in female rats is enhanced following chronic DA depletion.
    Carlsson M, Eriksson E.
    Life Sci; 1988 Aug; 42(5):585-8. PubMed ID: 3339950
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
    Jackson D, Carlsson A, Hjorth S, Lindberg P.
    J Neural Transm; 1982 Aug; 53(4):233-45. PubMed ID: 6286867
    [Abstract] [Full Text] [Related]

  • 30. Modifications of sleep parameters in the rat by (+)- and (-)-3-PPP.
    Kafi-de St Hilaire S, Sovilla JY, Hjorth S, Gaillard JM.
    J Neural Transm; 1985 Aug; 62(3-4):209-17. PubMed ID: 4031842
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.
    Clark D, Hjorth S, Carlsson A.
    J Neural Transm; 1985 Aug; 62(1-2):1-52. PubMed ID: 3894582
    [Abstract] [Full Text] [Related]

  • 33. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes.
    Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O.
    J Neural Transm; 1985 Aug; 64(3-4):187-98. PubMed ID: 3936899
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of the enantiomers of 3-PPP on DA1 and DA2 dopamine receptors in the dog.
    Kohli JD, Glock D, Goldberg LI.
    Eur J Pharmacol; 1985 Aug 27; 114(3):305-10. PubMed ID: 4065203
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.